Frontiers in Immunology (Jun 2019)

Protease Activated Receptor 4 as a Novel Modulator of Regulatory T Cell Function

  • Qi Peng,
  • Qi Peng,
  • Kulachelvy Ratnasothy,
  • Kulachelvy Ratnasothy,
  • Dominic A. Boardman,
  • Dominic A. Boardman,
  • Jacinta Jacob,
  • Jacinta Jacob,
  • Sim Lai Tung,
  • Sim Lai Tung,
  • Daniel McCluskey,
  • Lesley A. Smyth,
  • Lesley A. Smyth,
  • Robert I. Lechler,
  • Robert I. Lechler,
  • Anthony Dorling,
  • Anthony Dorling,
  • Giovanna Lombardi,
  • Giovanna Lombardi

DOI
https://doi.org/10.3389/fimmu.2019.01311
Journal volume & issue
Vol. 10

Abstract

Read online

Regulatory T cells (Tregs) are a subpopulation of T cells that maintain immunological tolerance. In inflammatory responses the function of Tregs is tightly controlled by several factors including signaling through innate receptors such as Toll like receptors and anaphylatoxin receptors allowing an effective immune response to be generated. Protease-activated receptors (PARs) are another family of innate receptors expressed on multiple cell types and involved in the pathogenesis of autoimmune disorders. Whether proteases are able to directly modulate Treg function is unknown. Here, we show using two complimentary approaches that signaling through PAR-4 influences the expression of CD25, CD62L, and CD73, the suppressive capacity, and the stability of Tregs, via phosphorylation of FoxO1 and negative regulation of PTEN and FoxP3. Taken together, our results demonstrate an important role of PAR4 in tuning the function of Tregs and open the possibility of targeting PAR4 to modulate immune responses.

Keywords